AAFMAA Wealth Management & Trust’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,839
Closed -$280K 50
2022
Q1
$280K Hold
3,839
0.13% 66
2021
Q4
$239K Buy
+3,839
New +$225K 0.1% 67
2021
Q1
Sell
-56,504
Closed -$3.5M 67
2020
Q4
$3.5M Buy
+56,504
New +$3.47M 1.69% 28

Other funds holding BMY

AAFMAA Wealth Management & Trust's BMY Position: Q2 2022 in Review

AAFMAA Wealth Management & Trust sold out of Bristol-Myers Squibb (BMY) in Q2 2022, closing a stake of 3,839 shares — an estimated $280K sold.

AAFMAA Wealth Management & Trust first reported a position in BMY in Q4 2020 and held it in 3 quarters. The position peaked at $3.5M in Q4 2020. 2,537 funds tracked by Wall St. Rank hold BMY as of Q2 2022.

  • AAFMAA Wealth Management & Trust reported no remaining Bristol-Myers Squibb position as of Q2 2022 after selling out during the quarter.
  • AAFMAA Wealth Management & Trust sold 3,839 Bristol-Myers Squibb shares in Q2 2022, an estimated $280K.
  • AAFMAA Wealth Management & Trust first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 3 quarters.
  • AAFMAA Wealth Management & Trust's Bristol-Myers Squibb position peaked at $3.5M in Q4 2020.
  • 2,537 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2022.

Based on AAFMAA Wealth Management & Trust's 13F filing for Q2 2022, filed 12 Aug 2022.